Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
fda decisions on new oncological drugs | 1.02 | 0.4 | 9030 | 1 | 38 |
fda | 1.65 | 0.2 | 8296 | 6 | 3 |
decisions | 0.44 | 0.1 | 6829 | 32 | 9 |
on | 1.45 | 0.6 | 3565 | 82 | 2 |
new | 1.95 | 0.5 | 7549 | 39 | 3 |
oncological | 1.57 | 0.7 | 4130 | 93 | 11 |
drugs | 1.6 | 0.4 | 4503 | 75 | 5 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda decisions on new oncological drugs | 1.63 | 0.5 | 4308 | 66 |
fda oncology new drug approvals | 0.18 | 0.4 | 9716 | 94 |
fda new oncology approvals | 1 | 0.4 | 3568 | 11 |
fda office of oncology drugs | 0.68 | 1 | 6546 | 19 |
fda newly approved oncology drugs | 0.96 | 0.3 | 9968 | 85 |
fda office of new drugs | 1.08 | 0.1 | 3934 | 35 |
fda investigational new drug guidance | 1.21 | 0.6 | 5533 | 39 |
fda investigational new drug | 0.13 | 0.3 | 7325 | 100 |
fda approved oncology drugs | 0.38 | 0.9 | 3161 | 43 |
what's new related to drugs fda | 0.85 | 0.8 | 8146 | 89 |
fda oncology drug approvals 2022 | 0.79 | 0.1 | 6994 | 79 |
us fda new drugs | 1.38 | 0.2 | 638 | 27 |
fda guidance oncology trial design | 0.38 | 0.2 | 3608 | 67 |
oncologic drugs advisory committee fda | 0.39 | 1 | 8749 | 15 |
new drug application fda guidance | 0.14 | 0.3 | 7934 | 46 |
fda approves new cancer drug | 1.82 | 0.9 | 9845 | 14 |
new drugs in oncology | 0.75 | 0.1 | 4628 | 14 |
fda division of oncology | 1.57 | 0.1 | 4445 | 73 |
new drug approvals in oncology | 1.34 | 0.6 | 7991 | 100 |
fda guidance combination oncology | 1.82 | 0.5 | 6554 | 13 |